BXP
17
2
WM
68
4
UNM
49
5
LUV
65
2
DE
66
10
WYNN
44
2
FLR
40
-3
FMC
30
-3
CHRW
48
6
CTSH
45
6
FOXA
20
6
PEP
74
-3
CMI
65
-3
AMP
37
2
APA
50
5
ABT
42
-8
RF
50
2
SCHW
52
2
VFC
61
2
URBN
47
7
BXP
17
2
WM
68
4
UNM
49
5
LUV
65
2
DE
66
10
WYNN
44
2
FLR
40
-3
FMC
30
-3
CHRW
48
6
CTSH
45
6
FOXA
20
6
PEP
74
-3
CMI
65
-3
AMP
37
2
APA
50
5
ABT
42
-8
RF
50
2
SCHW
52
2
VFC
61
2
URBN
47
7
Financhill
Back

TransMedics Group, Inc. 10K Form

Buy
78

TMDX
TransMedics Group, Inc.

Last Price:
$145.31
Seasonality Move:
29.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TMDX News And Ratings

See the #1 stock for the next 7 days that we like better than TMDX

TMDX Financial Statistics

Sales & Book Value

Annual Sales: $605.5M
Cash Flow: $19M
Price / Cash Flow: 40.84
Annual Sales: $13.81
Price / Book: 9.72

Profitability

EPS (TTM): 4.85710
Net Income (TTM): $190.3M
Gross Margin: $362.6M
Return on Equity: 57.97%
Return on Assets: 20.59%

TransMedics Group, Inc. Earnings Forecast

Key TransMedics Group, Inc. Financial Ratios

  • The Gross Profit Margin over the past 10 years for TMDX is 59.89%.
  • The Selling, General & Administrative Expenses for TMDX have been equal to 0.00% of Gross Profit Margin.
  • The Research & Development expenses have been 11.40% of Revenue.
  • The Interest Expense is 7.24% of Operating Income.
  • The Net Earning history of TMDX is 31.43% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 6 years.

TransMedics Group, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: TMDX
CUSIP: 89377M
Website: transmedics.com

Debt

Debt-to-Equity Ratio: 1.1
Current Ratio: 7.14
Quick Ratio: 6.41

Price-to-Earnings

Trailing P/E Ratio: 27.61
Forward P/E Ratio: 37.11

TMDX Technical Analysis vs Fundamental Analysis

Buy
78
TransMedics Group, Inc. (TMDX) is a Buy

Is TransMedics Group, Inc. a Buy or a Sell?